Enolate-Forming Compounds as a Novel Approach to Cytoprotection

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Plant-derived polyphenols (curcumin, resveratrol, phloretin) show therapeutic potential but face limitations like instability and low bioavailability.
• Pharmacophores of these compounds, such as 2-acetylcyclopentanone and 2',4',6'-trihydroxyacetophenone (THA), demonstrate cytoprotective effects.
• These pharmacophores are 1,3-dicarbonyl and polyphenol derivatives capable of forming enolates.

Purpose of the Study:

• To review evidence supporting the theory that enolate formation is a key cytoprotective property.
• To explore the potential of enolate-forming compounds as a platform for pharmacotherapeutic development.
• To discuss mechanism and structure-activity relationships in enolate chemistry and cytoprotection.

Main Methods:

• Investigated cytoprotection in cell culture and animal models of oxidative stress injury.
• Analyzed the chemical properties of 1,3-dicarbonyl and polyphenol derivatives.
• Examined the role of enolate formation in metal chelation and electrophile scavenging.
• Assessed the radical-trapping abilities of aromatic derivatives like THA.

Main Results:

• Enolate formation allows compounds to chelate metal ions and scavenge toxic electrophiles (e.g., acrolein, HNE, NAPQI).
• Aromatic derivatives like THA can trap reactive oxygen and nitrogen species, enhancing cytoprotection.
• Multifunctional enolate-forming compounds can inhibit pathogenic processes at multiple steps, including oxidative stress.

Conclusions:

• Enolate formation is a significant cytoprotective mechanism.
• Enolate-forming compounds represent a promising platform for developing treatments for toxic and pathogenic conditions.
• Understanding enolate chemistry and structure-activity relationships is crucial for designing effective pharmacotherapies.